Daniel C. Pevear

机构：VenatoRx Pharmaceuticals (United States)

发表论文 82 篇 · 总被引 5356 次 · h-index 35

代表论文

• An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge (2005 · Journal of Virology · 被引 468)
• Activity of Pleconaril against Enteroviruses (1999 · Antimicrobial Agents and Chemotherapy · 被引 371)
• Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections (2019 · Journal of Medicinal Chemistry · 被引 310)
• Efficacy and Safety of Oral Pleconaril for Treatment of Colds Due to Picornaviruses in Adults: Results of 2 Double-Blind, Randomized, Placebo-Controlled Trials (2003 · Clinical Infectious Diseases · 被引 309)
• The structure of coxsackievirus B3 at 3.5 å resolution (1995 · Structure · 被引 282)
• VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa (2019 · Antimicrobial Agents and Chemotherapy · 被引 222)